> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Optovue Epithelial Mapping Software
- URL: https://www.fdaweb.com/fda-clears-optovue-epithelial-mapping-software/
- Published: 2017-08-10T12:00:00.000Z
- Updated: 2026-09-14T22:40:19.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139361

FDA has cleared an Optovue 510(k) for its epithelial thickness mapping software for quantitative measurements of the epithelial and stromal layers of the cornea. Epi-mapping is intended to aid in the diagnosis, documentation and management of ocular health and diseases in the adult population, according to the company. “With epi-mapping, physicians are able to quantify epithelial thickness in patients in a manner that is suitable for daily clinical practice,” Optovue says. The software provides epithelial thickness information in a non-contact exam, whereas traditional epithelial measurements require high-frequency digital ultrasound and saline, it says.